REFERENCIAS
- Hume M, Sevitt
S, Thomas DP. Mechanisms of venous thromboembolism. In: Hume M, Sevitt
S, Thomas DP, eds. Venous Thrombosis and Pulmonary Embolism.
Cambridge, Mass: Harvard University Press; 1970:85-114.
- Coon WW, Willis
PW III, Keller JB. Venous thromboembolism and other venous disease
in the Tecumseh community health study. Circulation. 1973;48:839-846.
- Hull RD, Hirsh
J, Carter CJ, Jay RM, Dodd PE, Ockelford PA, Coates G, Gill GJ, Turpie
AGG, Doyle DJ, Buller HR, Raskob GE. Pulmonary angiography, ventilation
lung scanning, and venography for clinically suspected pulmonary embolism
with abnormal perfusion lung scan. Ann Intern Med. 1983;98:891-899.
- Hull RD, Hirsh
J, Carter CJ, Jay RM, Ockelford PA, Buller HR, Turpie AGG, Powers
P, Kinch D, Dodd PE, Gill GJ, Leclerc JR, Gent M. Diagnostic efficacy
of impedance plethysmography for clinically suspected deep-vein thrombosis:
a randomized trial. Ann Intern Med. 1985;102:21-28.
- Rubinstein I,
Murray D, Hoffstein V. Fatal pulmonary emboli in hospitalized patients:
an autopsy study. Arch Intern Med. 1988;148:1425-1426.
- Dalen JE, Alpert
JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis.
1975;17:259-270.
- Bell WR, Simon
TL. Current status of pulmonary thromboembolic disease: pathophysiology,
diagnosis, prevention, and treatment. Am Heart J. 1982;103:239-262.
- Kaunitz AM,
Hughes JM, Grimes DA, Smith JC, Rochat RW, Kafrissen ME. Causes of
maternal mortality in the United States. Obstet Gynecol. 1985;65:605-612.
- Freiman DG.
The structure of thrombi. In: Colman RW, Hirsh J, Marder VJ, Salzman
EW, eds. Thrombosis and Hemostasis: Basic Principles and Clinical
Practice. Philadelphia, Pa: JB Lippincott; 1987:1123-1135.
- Kakkar VV, Howe
CT, Flanc C, Clarke MB. Natural history of postoperative deep vein
thrombosis. Lancet. 1969;2:230-232.
- Nicolaides AN,
Kakkar VV, Field ES, Renney JT. The origin of deep vein thrombosis:
a venographic study. Br J Radiol. 1971;44:653-663.
- Stamatakis JD,
Kakkar VV, Sagar S, Lawrence D, Nairn D, Bentley PG. Femoral vein
thrombosis and total hip replacement. Br Med J. 1977;2:223-225.
- Hirsh J, Genton
E. Thrombogenesis. In: Root WS, Hofman FG, eds. Physiological Pharmacology:
A Comprehensive Treatise. New York, NY: Academic Press Inc; 1974:99-133.
- Wessler S, Yin
ET. On the mechanism of thrombosis. Prog Hematol. 1969;6:201-232.
- Davies GS, Salzman
EW. The pathogenesis of deep vein thrombosis. In: Joist HJ, Sherman
LA, eds. Venous and Arterial Thrombosis: Pathogenesis, Diagnosis,
Prevention, and Therapy. New York, NY: Grune & Stratton; 1979:1-22.
- Borgstrom S,
Gelin LE, Zenderfeld B. The formation of vein thrombi following tissue
injury. Acta Chir Scand Suppl. 1959;247:1-36.
- Moschos CB,
Khan MI, Regan TJ. Thrombogenic properties of blood during early ischemic
and nonischemic injury. Am J Physiol. 1971;220:1882-1884.
- Bjorklid E,
Giercksky KE, Prydz H. An immunoradiometric assay for factor III (tissue
thromboplastin). Br J Haematol. 1978;39:445-458.
- Kisiel W, Canfield
WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma
protein C following activation by thrombin. Biochemistry. 1977;16:5824-5831.
- Harpel PC, Rosenberg
RD. Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators
of hemostatic and inflammatory reactions. Prog Hemost Thromb.
1976;3:145-189.
- Rosenberg RD.
Hypercoagulability and methods for monitoring anticoagulant therapy.
In: Fratantoni J, Wessler S, eds. Prophylactic Therapy of Deep
Vein Thrombosis and Pulmonary Embolism Proceedings of a Conference.
Bethesda, Md: National Institutes of Health; 1975. US Dept of Health,
Education, and Welfare Publication NIH 76-866.
- Marlar RA, Kleiss
AJ, Griffin JH. Human protein C: inactivation of factors V and VIII
in plasma by the activated molecule. Ann N Y Acad Sci. 1981;370:303-310.
- Deykin D, Cochios
F, DeCamp G, Lopez A. Hepatic removal of activated factor X by the
perfused rabbit liver. Am J Physiol. 1968;214:414-419.
- Lee L. Reticuloendothelial
clearance of circulating fibrin in the pathogenesis of the generalized
Shwartzman reaction. J Exp Med. 1962;115:1065-1082.
- Collen D. On
the regulation and control of fibrinolysis: Edward Kowalski Memorial
Lecture. Thromb Haemost. 1980;43:77-89.
- Gallus AS, Hirsh
J. Treatment of venous thromboembolic disease. Semin Thromb Hemost.
1976;2:291-331.
- Browse NL, Thomas
ML. Source of non-lethal pulmonary emboli. Lancet. 1974;1:258-259.
- Browse NL, Clemenson
G, Croft DN. Fibrinogen-detectable thrombosis in the legs and pulmonary
embolism. Br Med J. 1974;1:603-604.
- Plate G, Ohlin
P, Eklof B. Pulmonary embolism in acute iliofemoral venous thrombosis.
Br J Surg. 1985;72:912-915.
- Corrigan TP,
Fossard DP, Spindler J, Armstrong P, Strachan CJ, Johnston KW, Kakkar
VV. Phlebography in the management of pulmonary embolism. Br J
Surg. 1974;61:484-488.
- Shull KC, Nicolaides
AN, Fernandes e Fernandes J, Miles C, Horner J, Needham T, Cooke ED,
Eastcott FH. Significance of popliteal reflux in relation to ambulatory
venous pressure and ulceration. Arch Surg. 1979;114:1304-1306.
- Kakkar VV, Howe
CT, Nicolaides AN, Renney JT, Clarke MB. Deep vein thrombosis of the
leg: is there a high risk group? Am J Surg. 1970;120:527-530.
- Prandoni P,
Lensing AWA, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM,
Polistena P, Bernardi E, Prins MH. The long-term clinical course of
acute deep-vein thrombosis. Ann Intern Med. In press.
- Zilliacus H.
On the specific treatment of thrombosis and pulmonary embolism with
anticoagulants, with a particular reference to the post thrombotic
sequelae. Acta Med Scand. 1946;170:1-221.
- Huisman MV,
Buller HR, ten Cate JW, Vreeken J. Serial impedance plethysmography
for suspected deep vein thrombosis in outpatients: the Amsterdam General
Practitioner Study. N Engl J Med. 1986;314:823-828.
- Hull R, Delmore
T, Carter C, Hirsh J, Genton E, Gent M, Turpie AGG, McLoughlin D.
Adjusted subcutaneous heparin vs warfarin sodium in the long-term
treatment of venous thrombosis. N Engl J Med. 1982;306:189-194.
- Hull R, Hirsh
J, Jay RM, Carter C, England C, Gent M, Turpie AGG, McLoughlin D,
Dodd P, Thomas M, Raskob G, Ockelford P. Different intensities of
oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
N Engl J Med. 1982;307:1676-1681.
- Hull R, Delmore
T, Genton E, Hirsh J, Gent M, Sackett D, McLoughlin D, Armstrong P.
Warfarin sodium versus low-dose heparin in the long-term treatment
of venous thrombosis. N Engl J Med. 1979;301:855-858.
- Salzman EW,
Deykin D, Shapiro RM, Rosenberg R. Management of heparin therapy:
controlled prospective trial. N Engl J Med. 1975;292:1046-1050.
- Glazier RL,
Crowell EB. Randomized prospective trial of continuous vs intermittent
heparin therapy. JAMA. 1976;236:1365-1367.
- Basu D, Gallus
A, Hirsh J, Cade J. A prospective study of the value of monitoring
heparin treatment with the activated partial thromboplastin time.
N Engl J Med. 1972;287:324-327.
- Prandoni P,
Lensing AWA, Buller HR, Carta M, Cogo A, Vigo AM, Casara D, Ruol A,
ten Cate JW. Comparison of subcutaneous low-molecular-weight heparin
with intravenous standard heparin in proximal deep-vein thrombosis.
Lancet. 1992;339:441-445.
- Brandjes DPM,
Heijboer H, de Rijk M, Jagt J, Buller HR, ten Cate JW, Huisman MV.
The effect of graded compression stockings on the development of the
post-thrombotic syndrome in patients with proximal deep-vein thrombosis.
Thromb Haemost. 1991;65(suppl):1131. Abstract.
- Prandoni P,
Lensing AWA, Buller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S,
Noventa F, ten Cate JW. Deep-vein thrombosis and the incidence of
subsequent symptomatic cancer. N Engl J Med. 1992;327:1128-1133.
- Hirsh J. The
optimal duration of anticoagulant therapy for venous thrombosis. N
Engl J Med. 1995;332:1710-1711.
- Levine MN, Hirsh
J, Gent M, Turpie AGG, Weitz J, Ginsberg J, Geerts W, Leclerc J, Neemeh
J, Powers P, Piovella F. Optimal duration of oral anticoagulant therapy:
a randomized trial comparing four weeks with three months of warfarin
in patients with proximal deep vein thrombosis. Thromb Haemost.
1995;74:606-611.
- Optimum duration
of anticoagulation for deep-vein thrombosis and pulmonary embolism.
Lancet. 1992;340:873-876.
- Hull RD, Carter
CJ, Jay RM, Ockelford PA, Hirsh J, Turpie AGG, Zielinsky A, Gent M,
Powers PJ. The diagnosis of acute, recurrent, deep-vein thrombosis:
a diagnostic challenge. Circulation. 1983;67:901-906.
- O'Donnell TF,
Browse NL, Burnand KG, et al. The socioeconomic effects of iliofemoral
venous thrombosis. J Surg Res. 1977;22:483-488.
- Cockett FB,
Thomas ML, Negus D. Iliac vein compression: its relation to iliofemoral
thrombosis and the post-thrombotic syndrome. Br Med J. 1967;2:14-19.
- Negus D. The
post-thrombotic syndrome. Ann R Coll Surg Engl. 1970;47:92-105.
- Jay R, Hull
R, Carter C, Ockelford P, Buller H, Turpie AGG, Hirsh J. Outcome of
abnormal impedance plethysmography results in patients with proximal-vein
thrombosis: frequency of return to normal. Thromb Res. 1984;36:259-263.
- Strandness DE
Jr, Langlois T, Cramer M, Randlett A, Thiele BL. Long-term sequelae
of acute venous thrombosis. JAMA. 1983;250:1289-1292.
- Gjores JE. The
incidence of venous thrombosis and its sequelae in certain districts
in Sweden. Acta Chir Scand. 1956;206:11-88.
- Lensing AWA,
Hirsh J. Rationale and results of thrombolytic therapy for deep vein
thrombosis. In: Bernstein EF, ed. Vascular Diagnosis. St Louis,
Mo: Mosby-Year Book, Inc; 1993:875-879.
- da Silva A,
Widmer LK, Martin H, Mall T, Glaus L, Schneider M. Varicose veins
and chronic venous insufficiency. Vasa. 1974;3:118-125.
- Ginsberg JS,
Shin A, Turpie AGG, Hirsh J. Detection of previous proximal venous
thrombosis with Doppler ultrasonography and photoplethysmography.
Arch Intern Med. 1989;149:2255-2257.
- Fernandes JF,
Horner J, Needham T, Nicolaides A. Ambulatory calf volume plethysmography
in the assessment of venous insufficiency. Br J Surg. 1979;66:327-330.
- Li J-M, Anderson
FA, Wheeler HB. Noninvasive testing for venous reflux using photoplethysmography:
standardization of technique and evaluation of interpretation criteria.
Bruit. 1983;7:25.
- Gallus AS, Salzman
EW, Hirsh J. Prevention of venous thromboembolism. In: Colman RW,
Hirsh J, Marder VJ, Salzman EW, eds. Haemostasis and Thrombosis:
Basic Principles and Clinical Practice. 3rd ed. Philadelphia,
Pa: JB Lippincott; 1994:1331-1345.
- Salzman EW,
Davies GC. Prophylaxis of venous thromboembolism: analysis of cost
effectiveness. Ann Surg. 1980;191:207-218.
- Collins R, Scrimgeour
A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous
thrombosis by perioperative administration of subcutaneous heparin:
overview of results of randomized trials in general, orthopedic, and
urologic surgery. N Engl J Med. 1988;318:1162-1173.
- Leyvraz PF,
Richard J, Bachmann F, Van Melle G, Treyvaud JM, Livio JJ, Candardjis
G. Adjusted versus fixed-dose subcutaneous heparin in the prevention
of deep-vein thrombosis after total hip replacement. N Engl J Med.
1983;309:954-958.
- Turpie AGG,
Hirsh J, Gent M, Julian D, Johnson J. Prevention of deep vein thrombosis
in potential neurosurgical patients: a randomized trial comparing
graduated compression stockings alone or graduated compression stockings
plus intermittent pneumatic compression with control. Arch Intern
Med. 1989;149:679-681.
- Hirsh J, Levine
MN. Low molecular weight heparin. Blood. 1992;79:1-77.
- Anderson DR,
O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J. Efficacy and
cost of low-molecular-weight heparin compared with standard heparin
for the prevention of deep vein thrombosis after total hip arthroplasty.
Ann Intern Med. 1993;119:1105-1112.
- Hull R, Delmore
TJ, Hirsh J, Gent M, Armstrong P, Lofthouse R, MacMillan A, Blackstone
I, Reed-Davis R, Detwiler RC. Effectiveness of intermittent pulsatile
elastic stockings for the prevention of calf and thigh vein thrombosis
in patients undergoing elective knee surgery. Thromb Res. 1979;16:37-45.
- Wille-Jorgensen
P, Thorup J, Fischer A, Holst-Christensen J, Flamsholt R. Heparin
with and without graded compression stockings in the prevention of
thromboembolic complications of major abdominal surgery: a randomized
trial. Br J Surg. 1985;72:579-581.
- Wille-Jorgensen
P, Christense BW, Bjerg-Nielsen A, Stadeager C, Kjaer L. Prevention
of thromboembolism following elective hip surgery: the value of regional
anesthesia and graded compression stockings. Clin Orthop. 1989;247:163-167.
- Powers PJ, Gent
M, Jay RM, Julian DH, Turpie AGG, Levine M, Hirsh J. A randomized
trial of less intense postoperative warfarin or aspirin therapy in
the prevention of venous thromboembolism after surgery for fractured
hip. Arch Intern Med. 1989;149:771-774.
- Leyvraz PF,
Bachmann F, Hoek J, Buller HR, Postel M, Samama M. Prevention of deep
vein thrombosis after hip replacement: randomised comparison between
unfractionated heparin and low molecular weight heparin. BMJ.
1991;303:543-548.
- Hull RD, Raskob
GE, Pineo G, Rosenbloom D, Evans W, Mallory T, Anquist K, Smith F,
Hughes G, Green D, Elliott G, Panju A, Brant R. A comparison of subcutaneous
low-molecular-weight heparin with warfarin sodium for prophylaxis
against deep-vein thrombosis after hip or knee implantation. N
Engl J Med. 1993;329:1370-1376.
- McLachlin J,
Richards T, Paterson JC. An evaluation of clinical signs in the diagnosis
of venous thrombosis. Arch Surg. 1962;85:738-744.
- Haeger K. Problems
of acute deep venous thrombosis, I: the interpretation of signs and
symptoms. Angiology. 1969;20:219-223.
- Johnston KW,
Kakkar VV. Plethysmographic diagnosis of deep vein thrombosis. Surg
Gynecol Obstet. 1974;139:41-44.
- Hull RD, Raskob
GE, LeClerc JR, Jay RM, Hirsh J. The diagnosis of clinically suspected
venous thrombosis. Clin Chest Med. 1984;5:439-456.
- Büller
HR, Lensing AWA, Hirsh J, ten Cate JW. Deep venous thrombosis: new
noninvasive tests. Thromb Haemost. 1991;66:133-137.
- Cogo A, Lensing
AWA, Prandoni P, Hirsh J. Distribution of thrombosis in patients with
deep-vein thrombosis: implications for simplifying the diagnostic
process with compression ultrasound. Arch Intern Med. 1993;153:2777-2780.
- Hull RD, Hirsh
J, Sackett DL, Taylor DW, Carter C, Turpie AGG, Powers P, Gent M.
Clinical validity of a negative venogram in patients with clinically
suspected venous thrombosis. Circulation. 1981;64:622-625.
- Wells PS, Hirsh
J, Anderson DR, Lensing AWA, Foster G, Kearon C, Weitz J, D'Ovidio
R, Cogo A, Prandoni P, Girolami A, Ginsberg JS. Accuracy of clnical
assessment of deep-vein thrombosis. Lancet. 1995;345:1326-1330.
- Thomas ML. Phlebography.
Arch Surg. 1972;104:145-151.
- Rabinov K, Paulin
S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg.
1972;104:134-144.
- Lensing AWA,
Buller HR, Prandoni P, Batchelor D, Molenaar AH, Cogo A, Vigo M, Huisman
PM, ten Cate JW. Contrast venography, the gold standard for the diagnosis
of deep-vein thrombosis: improvement in observer agreement. Thromb
Haemost. 1992;67:8-12.
- Hull R, van
Aken WG, Hirsh J, Gallus AS, Hoicka G, Turpie AGG, Walker I, Gent
M. Impedance plethysmography using the occlusive cuff technique in
the diagnosis of venous thrombosis. Circulation. 1976;53:696-700.
- Huisman MV,
Buller HR, ten Cate JW, Heijermans HSF, van der Laan J, van Maanen
DJ. Management of clinically suspected acute venous thrombosis in
outpatients with serial impedance plethysmography in a community hospital
setting. Arch Intern Med. 1989;149:511-513.
- Wheeler HB,
O'Donnell JA, Anderson FA Jr, Penney BC, Peura RA, Benedict C Jr.
Bedside screening for venous thrombosis using occlusive impedance
phlebography. Angiology. 1975;26:199-210.
- Wheeler HB,
Pearson D, O'Connell D, Mullick SC. Impedance phlebography: technique,
interpretation, and results. Arch Surg. 1972;104:164-169.
- Peters SHA,
Jonker JJC, de Boer AC, den Ottolander GJ. Home-diagnosis of deep
venous thrombosis with impedance plethysmography. Thromb Haemost.
1982;48:297-300.
- Wheeler HB,
Anderson FA Jr, Cardullo PA, Patwardhan NA, Jian-Ming L, Cutler BS.
Suspected deep-vein thrombosis: management by impedance plethysmography.
Arch Surg. 1982;117:1206-1209.
- Hull RD, Raskob
GE, Carter CJ. Serial impedance plethysmography in pregnant patients
with clinically suspected deep-vein thrombosis: clinical validity
of negative findings. Ann Intern Med. 1990;112:663-667.
- Foley WD, Middleton
WD, Lawson TL, Erickson S, Quiroz FA, Macrander S. Color Doppler ultrasound
imaging of lower-extremity venous disease. AJR Am J Roentgenol.
1989;152:371-376.
- Rose SC, Zwiebel
WJ, Nelson BD, Priest DL, Knighton RA, Brown JW, Lawrence PF, Stults
BM, Reading JC, Miller FJ. Symptomatic lower extremity deep venous
thrombosis: accuracy, limitations, and role of color duplex flow imaging
in diagnosis. Radiology. 1990;175:639-644.
- Baxter GM, McKechnie
S, Duffy P. Colour Doppler ultrasound in deep venous thrombosis: a
comparison with venography. Clin Radiol. 1990;42:32-36.
- Raghavendra
BN, Rosen RJ, Lam S, Riles T, Horii SC. Deep venous thrombosis: detection
by high-resolution real-time ultrasonography. Radiology. 1984;152:789-793.
- Elias A, Le
Corff G, Bouvier JL, Benichou M, Serradimgni A. Value of real time
B mode ultrasound imaging in the diagnosis of deep vein thrombosis
of the lower limbs. Int Angiol. 1987;6:175-182.
- Vogel P, Laing
FC, Jeffrey RB Jr, Wing VW. Deep venous thrombosis of the lower extremity:
US evaluation. Radiology. 1987;163:747-751.
- Cronan JJ, Dorfman
GS, Scola FH, Schepps B, Alexander J. Deep venous thrombosis: US assessment
using vein compression. Radiology. 1987;162:191-194.
- Monreal M, Montserrat
E, Salvador R, Bechini J, Donoso L, MaCallejas J, Foz M. Real-time
ultrasound for diagnosis of symptomatic venous thrombosis and for
screening of patients at risk: correlation with ascending conventional
venography. Angiology. 1989;40:527-533.
- Lensing AWA,
Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, Krekt J,
ten Cate JW, Huisman MV, Buller HR. Detection of deep-vein thrombosis
by real-time B-mode ultrasonography. N Engl J Med. 1989;320:342-345.
- Comerota AJ,
Katz ML, Greenwald LL, Leefmans E, Czeredarczuk M, White JV. Venous
duplex imaging: should it replace hemodynamic tests for deep venous
thrombosis. J Vasc Surg. 1990;11:53-61.
- Habscheid W,
Hohmann M, Wilhelm T, Epping J. Real-time ultrasound in the diagnosis
of acute deep venous thrombosis of the lower extremity. Angiology.
1990;41:599-608.
- Dauzat MM, Laroche
JP, Charras C, Blin B, Domingo-Faye MM, Sainte-Luce P, Domergue A,
Lopez FM, Janbon C. Real-time B-mode ultrasonography for better specificity
in the noninvasive diagnosis of deep venous thrombosis. J Ultrasound
Med. 1986;5:625-631.
- Schindler JM,
Kaiser M, Gerber A, Vuilliomenet A, Popovic A, Bertel O. Colour coded
duplex sonography in suspected deep vein thrombosis of the leg. BMJ.
1990;301:1369-1370.
- Persson AV,
Jones C, Zide R, Jewell ER. Use of the triplex scanner in diagnosis
of deep venous thrombosis. Arch Surg. 1989;124:593-596.
- Sumner DS, Londrey
GL, Spadone DP, Hodgson KJ, Leutz DW, Stauffer ES. Study of deep venous
thrombosis in high-risk patients using color flow Doppler. In: Bergan
JJ, Yao JST, eds. Venous Disorders. Philadelphia, Pa: WB Saunders;
1991:63-76.
- Wells PS, Brill-Edwards
P, Stevens P, Panju A, Patel A, Douketis J, Massicotte MP, Hirsh J,
Weitz JI, Kearon C, et al. A novel and rapid whole-blood assay for
D-dimer in patients with clinically suspected deep vein thrombosis.
Circulation. 1995;91:2184-2187.
- Mattos MA, Londrey
GL, Leutz DW, Hodgson KJ, Ramsey DE, Barkmeier LD, Stauffer ES, Spadone
DP, Sumner DS. Color-flow duplex scanning for the surveillance and
diagnosis of acute deep venous thrombosis. J Vasc Surg. 1992;15:366-375.
- Prandoni P,
Lensing AWA, Buller HR, Carta M, Vigo M, Cogo A, Cuppini S, ten Cate
JW. Failure of computerized impedance plethsmography in the diagnostic
management of patients with clinically suspected deep vein thrombosis.
Thromb Haemost. 1991;65:233-236.
- Hirsh J. Reliability
of non-invasive tests for the diagnosis of deep vein thrombosis. Thromb
Haemost. 1991;65:221-222.
- Anderson DR,
Lensing AWA, Wells PS, Levine MN, Weitz JI, Hirsh J. Limitations of
impedance plethysmography in the diagnosis of clinically suspected
deep-vein thrombosis. Ann Intern Med. 1993;118:25-30.
- Heijboer H,
Brandjes D, Lensing AWA, Buller HR, ten Cate JW. Efficacy of real-time
B-mode ultrasonography versus impedance plethysmography in the diagnosis
of deep vein thrombosis in symptomatic outpatients. Thromb Haemost.
1991;65:804. Abstract.
- Prandoni P,
Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, Noventa F,
Benedetti L, Girolami A. A simple ultrasound approach for detection
of recurrent proximal-vein thrombosis. Circulation. 1993;88(pt
1):1730-1735.
- Huisman MV,
Büller HR, ten Cate JW. Utility of impedance plethysmography
in the diagnosis of recurrent deep-vein thrombosis. Arch Intern
Med. 1988;148:681-683.
- Prandoni P,
Lensing AWA, Carta M, Cogo A, Villalta S, Ruol A. Elastic compression
stockings and the postphlebitic syndrome: an interim analysis of a
prospective cohort study in patients with proximal vein thrombosis.
Thromb Haemost. 1991;65:1579. Abstract.
- Common HH, Seaman
AJ, Rosch J, Porter CT, Dotter CT. Deep vein thrombosis treated with
streptokinase or heparin: follow-up of a randomized study. Angiology.
1976;27:645-654.
- Strandness DE
Jr, Langlois Y, Cramer M, Randlett A, Thiele BL. Long-term sequelae
of acute venous thrombosis. JAMA. 1983;250:1289-1292.
- Cronan JJ, Leen
V. Recurrent deep venous thrombosis: limitations of US. Radiology.
1989;170(pt 1):739-742.
- Heijboer H,
Jongbloets LMM, Buller HR, Lensing AW, ten Cate JW. Clinical utility
of real-time compression ultrasonography for diagnostic management
of patients with recurrent venous thrombosis. Acta Radiol Scand.
1992;33:297-300.
- Hull RD, Raskob
GE, Carter CJ, Coates G, Gill GJ, Sackett DL, Hirsh J, Thompson M.
Pulmonary embolism in outpatients with pleuritic chest pain. Arch
Intern Med. 1988;148:838-844.
- The urokinase
pulmonary embolism trial: a national cooperative study. Circulation.
1973;47(suppl 2):1-108.
- Bell WR, Simon
TL, DeMets DL. The clinical features of submassive and massive pulmonary
emboli. Am J Med. 1977;62:355-360.
- Hull RD, Hirsh
J, Carter CJ, Raskob GE, Gill GJ, Jay RM, Leclerc JR, David M, Coates
G. Diagnostic value of ventilation-perfusion lung scanning in patients
with suspected pulmonary embolism. Chest. 1985;88:819-828.
- Stein PD, Willis
PW III, DeMets DL. History and physical examination in acute pulmonary
embolism in patients without preexisting cardiac or pulmonary disease.
Am J Cardiol. 1981;47:218-223.
- Dalen JE, Grossman
W. Profiles in pulmonary embolism. In: Grossman W, ed. Cardiac
Catheterization and Angiography. Philadelphia, Pa: Lea & Febiger;
1980:336-345.
- Bell WR, Simon
TL. A comparative analysis of pulmonary perfusion scans with pulmonary
angiograms. Am Heart J. 1976;92:700-706.
- The PIOPED Investigators.
Value of the ventilation/perfusion scan in acute pulmonary embolism:
results of the prospective investigation of pulmonary embolism diagnosis
(PIOPED). JAMA. 1990;263:2753-2759.
- Bookstein JJ,
Silver TM. The angiographic differential diagnosis of acute pulmonary
embolism. Radiology. 1974;110:25-33.
- Novelline RA,
Baltarowich OH, Athanasoulis CA, Waltman AC, Greenfield AJ, McKusick
KA. The clinical course of patients with suspected pulmonary embolism
and a negative pulmonary arteriogram. Radiology. 1978;126:561-567.
- Bookstein JJ.
Segmental arteriography by pulmonary embolism. Radiology. 1969;93:1007-1012.
- Grollman JH
Jr, Gyepes MT, Helmer E. Transfemoral selective bilateral pulmonary
arteriography with a pulmonary-artery-seeking catheter. Radiology.
1970;96:202-204.
- Meyerovitz MF,
Levin DC, Harrington DP, Boxt LM, Bettmann MA, Garnic JD, Barry WH,
Geller SC. Evaluation of optimized biplane pulmonary cineangiography.
Invest Radiol. 1985;20:945-949.
- Stein PD, Athanasoulis
C, Alavi A, Greenspan RH, Hales CA, Salzman HA, Vreim CE, Terrin ML,
Weg JG. Complications and validity of pulmonary angiography in acute
pulmonary embolism. Circulation. 1982;85:462-468.
- Hull RD, Raskob
GE, Coates G, Panju AA. Clinical validity of a normal perfusion lung
scan in patients with suspected pulmonary embolism. Chest.
1990;97:23-26.
- Kipper MS, Moser
KM, Kortman KE, Ashburn WL. Longterm follow-up of patients with suspected
pulmonary embolism and a normal lung scan: perfusion scans in embolic
suspects. Chest. 1982;82:411-415.
- Szucs MM Jr,
Brooks HL, Grossman W, Banas JS Jr, Meister G, Dexter L, Dalen JE.
Diagnostic sensitivity of laboratory findings in acute pulmonary embolism.
Ann Intern Med. 1971;74:161-166.
- Weber DM, Phillips
JH Jr. A re-evaluation of electrocardiographic changes accompanying
acute pulmonary embolism. Am J Med Sci. 1966;251:381-398.
- McNeil BJ. Ventilation-perfusion
studies and the diagnosis of pulmonary embolism: concise communication.
J Nucl Med. 1980;21:319-323.
- Biello DR, Mattar
AG, McKnight RC, Siegel BA. Ventilation-perfusion studies in suspected
pulmonary embolism. AJR Am J Roentgenol. 1979;133:1033-1037.
- Alderson PO,
Rujanavech N, Sicker-Walker RH, McKnight RC. The role of 133Xe
ventilation studies in the scintigraphic detection of pulmonary embolism.
Radiology. 1976;120:633-640.
- Cheely R, McCartney
WH, Perry JR, Delany DJ, Bustad L, Wynia VH, Griggs TR. The role of
noninvasive tests versus pulmonary angiography in the diagnosis of
pulmonary embolism. Am J Med. 1981;70:17-22.
- Weitz JI, Hudoba
M, Massel D, Maraganore J, Hirsh J. Clot-bound thrombin is protected
from inhibition by heparin-antithrombin III but is susceptible to
inactivation by antithrombin III-independent inhibitors. J Clin
Invest. 1990;86:385-391.
- Barritt DW,
Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism:
a controlled trial. Lancet. 1960;1:1309-1312.
- Hull R, Delmore
T, Genton E, Hirsh J, Gent M, Sackett D, McLoughlin D, Armstrong P.
Warfarin sodium versus low-dose heparin in the long-term treatment
of venous thrombosis. N Engl J Med. 1979;301:855-858.
- Brandjes DPM,
Heijboer H, Buller HR, de Rijk M, Jagt H, ten Cate JW. Acenocoumarol
and heparin compared with acenocoumarol alone in the initial treatment
of proximal-vein thrombosis. N Engl J Med. 1992;327:1485-1489.
- Lagerstedt CI,
Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Need for long-term
anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet.
1985;2:515-518.
- Cruickshank
MK, Levine MN, Hirsh J, Roberts R, Siquenza M. A standard heparin
nomogram for the management of heparin therapy. Arch Intern Med.
1991;151:333-337.
- Hirsh J. Heparin.
N Engl J Med. 1991;324:1565-1574.
- Pini M, Pattachini
C, Quintavalla R, Poli T, Megha A, Tagliaferri A, Manotti C, Dettori
AG. Subcutaneous vs intravenous heparin in the treatment of deep venous
thrombosis: a randomized clinical trial. Thromb Haemost. 1990;64:222-226.
- Raschke RA,
Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin
dosing nomogram compared with a standard care nomogram: a randomized
controlled trial. Ann Intern Med. 1993;119:874-881.
- Gallus A, Jackaman
J, Tillett J, Mills W, Wycherley A. Safety and efficacy of warfarin
started early after submassive venous thrombosis or pulmonary embolism.
Lancet. 1986;2:1293-1296.
- Hull RD, Raskob
GE, Rosenbloom D, Panju AA, Brill-Edwads P, Ginsberg JS, Hirsh J,
Martin GJ, Green D. Heparin for 5 days as compared with 10 days in
the initial treatment of proximal venous thrombosis. N Engl J Med.
1990;322:1260-1264.
- Chiu HM, Hirsh
J, Yung WL, Regoeczi E, Gent M. Relationship between the anticoagulant
and antithrombotic effects of heparin in experimental venous thrombosis.
Blood. 1977;49:171-184.
- Hull RD, Raskob
GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH, Rosenbloom D, Sackett
DL, Anderson C, Harrison L, Gent M. Continuous intravenous heparin
compared with intermittent subcutaneous heparin in the initial treatment
of proximal-vein thrombosis. N Engl J Med. 1986;315:1109-1114.
- Bjornsson JD,
Nash PV. Variability in heparin sensitivity of aPTT reagents. Am
J Clin Pathol. 1986;86:199-204.
- Hirsh J, van
Aken WG, Gallus AS, Dollery CT, Cade JF, Yung WL. Heparin kinetics
in venous thrombosis and pulmonary embolism. Circulation. 1976;53:691-695.
- Young E, Prins
M, Levine MN, Hirsh J. Heparin binding to plasma proteins, an important
mechanism for heparin resistance. Thromb Haemost. 1992;67:639-643.
- Young E, Cosmi
B, Weitz J, Hirsh J. Comparison of the non-specific binding of unfractionated
heparin and low molecular weight heparin to plasma proteins. Thromb
Haemost. 1993;70:625-630.
- Levine MN, Hirsh
J, Gent M, Turpie AGG, Cruickshank M, Weitz J, Anderson D, Johnston
M. A randomized trial comparing the activated thromboplastin time
with heparin assay in patients with acute venous thromboembolism requiring
large daily doses of heparin. Arch Intern Med. 1994;154:49-56.
- Brill-Edwards
P, Ginsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range
for heparin therapy. Ann Intern Med. 1993;119:104-109.
- Doyle DJ, Turpie
AGG, Hirsh J, Best C, Kinch D, Levine MN, Gent M. Adjusted subcutaneous
heparin or continuous intravenous heparin in patients with acute deep
vein thrombosis: a randomized trial. Ann Intern Med. 1987;107:441-445.
- Bentley PG,
Kakkar VV, Scully MF, MacGregor IR, Webb P, Chan P, Jones N. An objective
study of alternative methods of heparin administration. Thromb
Res. 1980;18:177-187.
- Andersson G,
Fagrell B, Holmgren K, Johnsson H, Ljungberg B, Nilsson E, Wilhelmsson
S, Zetterquist S. Subcutaneous administration of heparin: a randomised
comparison with intravenous administration of heparin to patients
with deep-vein thrombosis. Thromb Res. 1982;27:631-639.
- Walker MG, Shaw
JW, Thomson GJL, Cumming JGR, Thomas ML. Subcutaneous calcium heparin
versus intravenous sodium heparin in treatment of established acute
deep vein thrombosis of the legs: a multicentre prospective randomised
trial. Br J Med (Clin Res Ed). 1987;294:1189-1192.
- Monreal M, Lafoz
E, Olive A, del Rio L, Vedia C. Comparison of subcutaneous unfractionated
heparin with a low molecular weight heparin (Fragmin) in patients
with venous thromboembolism and contraindications to coumarin. Thromb
Haemost. 1994;71:7-11.
- Ginsberg JS,
Hirsh J, Turner DC, Levine MN, Burrows R. Risk to the fetus of anticoagulant
therapy during pregnancy. Thromb Haemost. 1989;61:197-203.
- Forestier F,
Daffos F, Capella-Pavolvsky M. Low molecular weight heparin (PK 10169)
does not cross the placenta during the second trimester of pregnancy:
study by direct fetal blood sampling under ultrasound. Thromb Res.
1984;34:557-560.
- Forestier F,
Daffos F, Rainaut M, Toulemonde F. Low molecular weight heparin (CY
216) does not cross the placenta during the third trimester of pregnancy.
Thromb Haemost. 1987;57:234. Letter.
- Omri A, Delaloye
JF, Andersen H, Bachmann F. Low molecular weight heparin Novo (LHN-1)
does not cross the placenta during the second trimester of pregnancy.
Thromb Haemost. 1989;61:55-56.
- Melissari E,
Das S, Kanthou C, Pemberton KD, Kakkar VV. The use of LMW heparin
in treating thromboembolism during pregnancy and prevention of osteoporosis.
Thromb Haemost. 1991;65:926. Abstract.
- Warkentin TE,
Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced
thrombocytopenia in patients treated with low-molecular-weight heparin
or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.
- Khamashta MA,
Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management
of thrombosis in the antiphospholipid-antibody syndrome. N Engl
J Med. 1995;332:993-997.
- Violi F, Ferro
D, Valesini G. Thrombosis in the antiphospholipid antibody syndrome.
N Engl J Med. 1995;333:665. Letter.
- Derksen RHWM,
de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid
antibodies and venous thrombosis should receive long term anticoagulant
treatment. Ann Rheum Dis. 1993;52:689-692.
- Ginsberg JS,
Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens
P, Hirsh J. Antiphospholipid antibodies and venous thromboembolism.
Blood. 1995;86:3685-3691.
- Wessler S, Gitel
SN. Warfarin: from bedside to bench. N Engl J Med. 1984;311:645-652.
- Zivelin A, Rao
LV, Rapaport SI. Mechanism of the anticoagulant effect of warfarin
as evaluated in rabbits by selective depression of individual procoagulant
vitamin K-dependent clotting factors. J Clin Invest. 1993;92:2131-2140.
- O'Sullivan EF.
Duration of anticoagulant therapy in venous thromboembolism. Med
J Aust. 1972;2:1104-1107.
- Schulman S,
Lockner D, Juhlin-Dannfelt A. The duration of oral anticoagulation
after deep vein thrombosis: a randomized study. Acta Med Scand.
1985;217:547-552.
- Holmgren K,
Andersson G, Fagrell B, Johnsson H, Ljungberg B, Nilsson E, Wilhelmsson
S, Zetterquist S. One-month versus six-month therapy with oral anticoagulants
after symptomatic deep vein thrombosis. Acta Med Scand. 1985;218:279-284.
- Prandoni P,
Lensing AWA, Buller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S,
Noventa F, ten Cate JW. Deep-vein thrombosis and the incidence of
subsequent symptomatic cancer. N Engl J Med. 1992;327:1128-1133.
- Schulman S,
Rhedin AS, Lindmarker P, Carlsson A, Lators G, Nicol P, Loogna E,
Svensson E, Ljungberg B, Walter H, et al. A comparison of six weeks
with six months of oral anticoagulation after a first episode of venous
thromboembolism: Duration of Anticoagulation Trial Study Group. N
Engl J Med. 1995;332:1661-1665.
- Levine MN, Gent
M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, De Pauw S. The thrombogenic
effect of anticancer drug therapy in women with stage II breast cancer.
N Engl J Med. 1988;318:404-407.
- Goldhaber SZ,
Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized
trials of streptokinase and heparin in phlebographically documented
acute deep venous thrombosis. Am J Med. 1984;76:393-397.
- Tibbutt DA,
Davies JA, Anderson JA, Fletcher EWL, Hamill J, Holt JM, Thomas ML,
Lee GDJ, Miller GAH, Sharp AA, Sutton GC. Comparison by controlled
clinical trial of streptokinase and heparin in treatment of life-threatening
pulmonary embolism. Br Med J. 1974;1:343-347.
- Miller GAH,
Sutton GC, Kerr IH, Gibson RV, Honey M. Comparison of streptokinase
and heparin in the treatment of isolated acute massive pulmonary embolism.
Br Med J. 1971;2:681-684.
- Anderson DR,
Levine MN. Thrombolytic therapy for the treatment of acute pulmonary
embolism. Can Med Assoc J. 1992;146:1317-1324.
- Elliot MS, Immelman
EJ, Jeffery P, Benatar SR, Funston MR, Smith JA, Shepstone BJ, Ferguson
AD, Jacobs P, Walker W, Louw JH. A comparative randomized trial of
heparin versus streptokinase in the treatment of acute proximal vein
thrombosis: an interim report of a prospective trial. Br J Surg.
1979;66:838-843.
- Coon WW. Operative
therapy of venous thromboembolism. Mod Concepts Cardiovasc Dis.
1974;43:71-75.
- Mobin-Uddin
K, Callard GM, Bolooki H, Rubinson R, Michie D, Jude JR. Transvenous
caval interruption with an umbrella filter. N Engl J Med. 1972;286:55-58.
- Mobin-Uddin
K. The intracaval umbrella in prevention of pulmonary embolism. In:
Bergan JJ, Yao JST, eds. Venous Problems. Chicago, Ill: Year
Book Medical Publishers Inc; 1978:333-346.
- Wingerd M, Bernhard
VM, Maddison F, Towne JB. Comparison of caval filters in the management
of venous thromboembolism. Arch Surg. 1978;113:1264-1271.
- Adelson J, Steer
ML, Glotzer DJ, Skillman JJ, Simon M, Salzman EW. Thromboembolism
after insertion of the Mobin-Uddin caval filter. Surgery. 1980;87:184-189.
- Schroeder TM,
Elkins RC, Greenfield LJ. Entrapment of sized emboli by the KMA-Greenfield
intracaval filter. Surgery. 1978;83:435-439.
- Magnant JG,
Walsh DB, Juravsky LI, Cronenwett JL. Current use of inferior vena
cava filters. J Vasc Surg. 1992;16:701-706.
- Roehm JO Jr.
The bird's nest filter: a new percutaneous transcatheter inferior
vena cava filter. J Vasc Surg. 1984;1:498-501.
- Hunter JA, Sessions
R, Petasnick J. Therapeutic balloon occlusion of the inferior vena
cava. JAMA. 1975;234:1034-1037.
- Moser KM, Harsany
PG, Harvey-Smith W, Durante PL, Guisan M. Reversible interruption
of inferior vena cava by means of a balloon catheter: preliminary
report. J Thorac Cardiovasc Surg. 1971;62:205-212.
- Hunter JA, DeLaria
GA, Goldin MD, Serry C, Monson DO, DaValle MJ, Najafi H. Inferior
vena cava interruption with the Hunter-Sessions balloon: eighteen
years' experience in 191 cases. J Vasc Surg. 1989;10:450-456.
- Lansing AM,
Davis WM. Five-year follow-up study of iliofemoral venous thrombectomy.
Ann Surg. 1968;168:620-628.
- Miller GAH,
Hall RJC, Paneth M. Pulmonary embolectomy, heparin, and streptokinase:
their place in the treatment of acute massive pulmonary embolism.
Am Heart J. 1977;93:568-574.
- Donaldson GA,
Williams C, Scannell JG, Shaw RG. A reappraisal of the application
of the Trendelenburg operation for massive fatal embolism. N Engl
J Med. 1963;268:171-174.
- Moser KM, Daily
PO, Peterson K, Dembitsky W, Vapnek JM, Shure D, Utley J, Archibald
C. Thromboendarterectomy for chronic, major-vessel thromboembolic
pulmonary hypertension: immediate and long-term results in 42 patients.
Ann Intern Med. 1987;107:560-565.
- Moser KM, Auger
WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension.
Circulation. 1990;81:1735-1743.
- Painter TD,
Karpf M. Deep venous thrombosis of the upper extremity: five years'
experience at a university hospital. Angiology. 1984;35:743-749.
- Becker DM, Philbrick
JT, Walker FB IV. Axillary and subclavian venous thrombosis: prognosis
and treatment. Arch Intern Med. 1991;151:1934-1943.
- Lindblad B,
Tengborn L, Bergqvist D. Deep vein thrombosis of the axillary-subclavian
veins: epidemiologic data, effects of different types of treatment
and late sequelae. Eur J Vasc Surg. 1988;2:161-165.
- Thaler E, Lechner
K. Antithrombin III deficiency and thromboembolism. Clin Haematol.
1981;10:369-390.
- Engesser L,
Broekmans AW, Briet E, Brommer EJ, Bertina RM. Hereditary protein
S deficiency: clinical manifestations. Ann Intern Med. 1987;106:677-682.
- Girolami A,
Marafioti F, Rubertelli M, Cappellato MG. Congenital heterozygous
plasminogen deficiency associated with a severe thrombotic tendency.
Acta Haematol. 1986;75:54-57.
- Mackworth-Young
CG, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features
of patients with raised anticardiolipin antibodies and no other disorder.
Ann Rheum Dis. 1989;48:362-367.
- Monreal M, Lafoz
E, Ruiz J, Valls R, Alastrue A. Upper-extremity deep venous thrombosis
and pulmonary embolism: a prospective study. Chest. 1991;99:280-283.
- Horattas MC,
Wright DJ, Fenton AH, Evans DM, Oddi MA, Kamienski RW, Shields EF.
Changing concepts of deep venous thrombosis of the upper extremity:
report of a series and review of the literature. Surgery. 1988;104:561-567.
- Martin EC, Koser
M, Gordon DH. Venography in axillary-subclavian vein thrombosis. Cardiovasc
Radiol. 1979;2:261-266.
- Lindblad B,
Bornmyr S, Kullendorff B, Bergqvist D. Venous haemodynamics of the
upper extremity after subclavian vein thrombosis. Vasa. 1990;19:218-222.
- Donayre CE,
White GH, Mehringer SM, Wilson SE. Pathogenesis determines late morbidity
of axillosubclavian vein thrombosis. Am J Surg. 1986;152:179-184.
- Tilney ML, Griffiths
HJ, Edwards EA. Natural history of major venous thrombosis of the
upper extremity. Arch Surg. 1970;101:792-796.
- Machleder HI.
Evaluation of a new treatment strategy for Paget-Schroetter syndrome:
spontaneous thrombosis of the axillary-subclavian vein. J Vasc
Surg. 1993;17:305-315.
- Haire WD, Lynch
TG, Lieberman RP, Lund GB, Edney JA. Utility of duplex ultrasound
in the diagnosis of asymptomatic catheter-induced subclavian vein
thrombosis. J Ultrasound Med. 1991;10:493-496.
- Machleder HI.
The role of thrombolytic agents for acute subclavian vein thrombosis.
Semin Vasc Surg. 1992;5:82.
- Becker GJ, Holden
RW, Rabe FE, Castaneda-Zuniga WR, Sears N, Dilley RS, Glover JL. Local
thrombolytic therapy for subclavian and axillary vein thrombosis:
treatment of the thoracic inlet syndrome. Radiology. 1983;149:419-423.
- McNamara TO,
Fischer JR. Thrombolysis of peripheral arterial and graft occlusions:
improved results using high-dose urokinase. AJR Am J Roentgenol.
1985;144:769-775.
- Kleinsasser
LJ. "Effort" thrombosis of the axillary and subclavian veins.
Arch Surg. 1949;59:258.
- Smith VC, Hallett
JW Jr. Subclavian vein thrombosis during prolonged catheterization
for parenteral nutrition: early management and long-term follow-up.
South Med J. 1983;76:603-606.
- Axelsson CK,
Efsen F. Phlebography in long-term catheterization of the subclavian
vein: a retrospective study in patients with severe gastrointestinal
disorders. Scand J Gastroenterol. 1978;13:933-938.
- Campbell CB,
Chandler JG, Tegtmeyer CJ, Bernstein EF. Axillary, subclavian, and
brachiocephalic vein obstruction. Surgery. 1977;82:816-826.
- Wilson JJ, Lesk
D, Newman H. Subclavian-axillary vein thrombosis: successful treatment
with streptokinase. Can Med Assoc J. 1984;130:891-893.
- Appleby DH,
Heller MS. Low-dose streptokinase therapy for subclavian vein thrombosis.
South Med J. 1984;77:536-537.
- Rubenstein M,
Creger WP. Successful streptokinase therapy for catheter-induced subclavian
vein thrombosis. Arch Intern Med. 1980;140:1370-1371.
- Fraschini G,
Jadeja J, Lawson M, Holmes FA, Carrasco HC, Wallace S. Local infusion
of urokinase for the lysis of thrombosis associated with permanent
central venous catheters in cancer patients. J Clin Oncol.
1987;5:672-678.
- Druy EM, Trout
HH III, Giordano JM, Hix WR. Lytic therapy in the treatment of axillary
and subclavian vein thrombosis. J Vasc Surg. 1985;2:821-827.
- Ginsberg JS,
Brill-Edwards P, Burrows RF, Bona R, Prandoni P, Buller HR, Lensing
A. Venous thrombosis during pregnancy: leg and trimester of presentation.
Thromb Haemost. 1992;67:519-520.
- Demers C, Ginsberg
JS. Deep venous thrombosis and pulmonary embolism in pregnancy. Clin
Chest Med. 1992;13:645-656.
- Ginsberg JS,
Hirsh J, Turner DC, Levine MN, Burrows R. Risks to the fetus of anticoagulant
therapy during pregnancy. Thromb Haemost. 1989;61:197-203.
- Hall JAG, Pauli
RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during
pregnancy. Am J Med. 1980;68:122-140.
- Ginsberg JS,
Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R. Heparin therapy
during pregnancy: risks to the fetus and mother. Arch Intern Med.
1989;149:2233-2236.
- Iturbe-Alessio
I, Fonseca MC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks
of anticoagulant therapy in pregnancy women with artificial heart
valves. N Engl J Med. 1986;315:1390-1393.
- Anderson DR,
Ginsberg JS, Burrows R, Brill-Edwards P. Subcutaneous heparin therapy
during pregnancy: a need for concern at the time of delivery. Thromb
Haemost. 1991;65:248-250.
- Hirsh J, van
Aken WG, Gallus AS, Dollery CT, Cade JF, Yung WL. Heparin kinetics
in venous thrombosis and pulmonary embolism. Circulation. 1976;53:691-695.
- McKenna R, Cole
ER, Vasan U. Is warfarin sodium contraindicated in the lactating mother?
J Pediatr. 1983;103:325-327.
- Orme ML, Lewis
PJ, de Swiet M, Serlin MJ, Sibeon R, Baty JD, Breckenridge AM. May
mothers given warfarin breast-feed their infants? Br Med J.
1977;1:1564-1565.
- Delclos GL,
Davila F. Thrombolytic therapy for pulmonary embolism in pregnancy:
a case report. Am J Obstet Gynecol. 1986;155:375-376.
- Hall RJ, Young
C, Sutton GC, Cambell S. Treatment of acute massive pulmonary embolism
by streptokinase during labour and delivery. Br Med J. 1972;4:647-649.
- Henny CP, ten
Cate H, ten Cate JW, Prummel MF, Peters M, Buller HR. Thrombosis prophylaxis
in an AT III deficient pregnant woman: application of a low molecular
weight heparinoid. Thromb Haemost. 1986;55:301. Letter.
- Priollet P,
Roncato M, Aiach M, Housset E, Poissonnier MH, Chavinie J. Low-molecular-weight
heparin in venous thrombosis during pregnancy. Br J Haematol.
1986;63:605-606.
- Carter C, Gent
M. The epidemiology of venous thrombosis. In: Colman R, Hirsh J, Marder
V, Salzman E, eds. Haemostasis and Thrombosis: Basic Principles
and Clinical Practice. Philadelphia, Pa: JB Lippincott Co; 1982:805-819.
- Castaman G,
Rodeghiero F, Dini E. Thrombotic complications during L-asparaginase
treatment for acute lymphocytic leukemia. Haematologica. 1990;75:567-569.
- Wise RC, Todd
JK. Spontaneous, lower-extremity venous thrombosis in children. Am
J Dis Child. 1973;126:766-769.
- Bernstein D,
Coupey S, Schonberg SK. Pulmonary embolism in adolescents. Am J
Dis Child. 1986;140:667-671.
- Uden A. Thromboembolic
complications following scoliosis surgery in Scandinavia. Acta
Orthop Scand. 1979;50:175-178.
- Andrew M, David
M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L,
Cairney B, DeSai D, Grant R, Israels S, Jardine L, Luke B, Massicotte
P, Silva M. Venous thromboembolic complications (VTE) in children:
first analyses of the Canadian Registry of VTE. Blood. 1994;83:1251-1257.
- David M, Andrew
M. Venous thromboembolic complications in children. J Pediatr.
1993;123:337-346.
- Schmidt B, Andrew
A. A prospective international registry of neonatal thrombotic diseases.
Pediatr Res. 1994;35(pt 2):170a. Abstract.
- Green RM, Meyer
TJ, Dunn M, Glassroth J. Pulmonary embolism in younger adults. Chest.
1992;101:1507-1511.
- Lindblad B,
Bergqvist D. Aggressive or conservative treatment in subclavian vein
thrombosis. In: Eklof B, Gjores J, Thulesius O, Bergqvist D, eds.
Controversies in the Management of Venous Disorders: Scandinavian
Contributions on Venous Problems With Comments by International Authorities.
London, UK: Butterworths; 1989:141-158.
- Rockoff MA,
Gang DL, Vacanti JP. Fatal pulmonary embolism following removal of
a central venous catheter. J Pediatr Surg. 1984;19:307-309.
- Mulvihill SJ,
Fonkalsrud EW. Complications of superior versus inferior vena cava
occlusion in infants receiving central total parenteral nutrition.
J Pediatr Surg. 1984;19:752-757.
- Mollitt DL,
Golladay ES. Complications of TPN catheter-induced vena caval thrombosis
in children less than one year of age. J Pediatr Surg. 1983;18:462-467.
- Le Coultre C,
Oberhansli I, Mossaz A, Bugmann P, Faidutti B, Belli DC. Postoperative
chylothorax in children: differences between vascular and traumatic
origin. J Pediatr Surg. 1991;26:519-523.
- Tanaka K, Takao
M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagulation
and fibrinolysis associated with cardiopulmonary bypass during open
heart surgery. J Cardiothorac Anesth. 1989;3:181-188.
- Graham L Jr,
Gumbiner CH. Right atrial thrombus and superior vena cava syndrome
in a child. Pediatrics. 1984;73:225-229.
- Bertrand M,
Presant CA, Klein L, Scott E. Iatrogenic superior vena cava syndrome:
a new entity. Cancer. 1984;54:376-378.
- Kramer SS, Taylor
GA, Garfinkel DJ, Simmons MA. Lethal chylothoraces due to superior
vena caval thrombosis in infants. AJR Am J Roentgenol. 1981;137:559-563.
- Dhande V, Kattwinkel
J, Alford B. Recurrent bilateral pleural effusions secondary to superior
vena cava obstruction as a complication of central venous catheterization.
Pediatrics. 1983;72:109-113.
- Duke W. The
relation of blood platelets to hemorrhagic disease: description of
a method for determining the bleeding time and coagulation time and
report of three cases of hemorrhagic disease relieved by transfusion.
JAMA. 1910;55:1185-1192.
- Andrew M, Marzinotto
V, Pencharz P, Zlotkin S, Burrows P, Ingram J, Adams M, Filler R.
A cross-sectional study of catheter-related thrombosis in children
receiving total parenteral nutrition at home. J Pediatr. 1995;126:358-363.
- Rajani K, Goetzman
BW, Wennberg RP, Turner E, Abildgaard C. Effect of heparinization
of fluids infused through an umbilical artery catheter on catheter
patency and frequency of complications. Pediatrics. 1979;63:552-556.
- David R, Merten
D, Anderson JC, Gross S. Prevention of umbilical artery catheter clots
with heparinized infusates. Dev Pharmacol Ther. 1981;2:117-126.
- Bosque E, Weaver
L. Continuous versus intermittent heparin infusion of umbilical artery
catheters in the newborn infant. J Pediatr. 1986;108:141-143.
- Horgan MJ, Bartoletti
A, Polansky S, Peters JC, Manning TJ, Lamont BM. Effect of heparin
infusates in umbilical arterial catheters on frequency of thrombotic
complications. J Pediatr. 1987;111:774-778.
- Ankola PA, Atakent
YS. Effect of adding heparin in very low concentration to the infusate
to prolong the patency of umbilical artery catheters. Am J Perinatol.
1993;10:229-232.
- Salzman EW,
Deykin D, Shapiro RM, Rosenberg R. Management of heparin therapy:
controlled prospective trial. N Engl J Med. 1975;292:1046-1050.
- Hommes DW, Bura
A, Mazzolai L, Buller HR, ten Cate JW. Subcutaneous heparin compared
with continuous intravenous heparin administration in the initial
treatment of deep vein thrombosis: a meta-analysis. Ann Intern
Med. 1992;116:279-284.
- Hirsh J, Dalen
JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics,
dosing considerations, monitoring, efficacy, and safety. Chest.
1992;102(suppl 4):337S-351S.
- de Swart CAM,
Nijmeyer B, Roelofs JMM, Sixma JJ. Kinetics of intravenously administered
heparin in normal humans. Blood. 1982;60:1251-1258.
- Olsson P, Lagergren
H, Ek S. The elimination from plasma of intravenous heparin: an experimental
study on dogs and humans. Acta Med Scand. 1963;173:619-630.
- Bjornsson TD,
Wolfram KM, Kitchell BB. Heparin kinetics determined by three assay
methods. Clin Pharmacol Ther. 1982;31:104-113.
- Racanelli A,
Fareed J, Walenga JM, Coyne E. Biochemical and pharmacologic studies
on the protamine interactions with heparin, its fractions and fragments.
Semin Thromb Hemost. 1985;11:176-189.
- Sharath MD,
Metzger WJ, Richerson HB, Scupham RK, Meng RL, Ginsberg BH, Weiler
JM. Protamine-induced fatal anaphylaxis: prevalence of antiprotamine
immunoglobulin E antibody. J Thorac Cardiovasc Surg. 1985;90:86-90.
- Shapira N, Schaff
HV, Piehler JM, White RD, Still JC, Pluth JR. Cardiovascular effects
of protamine sulfate in man. J Thorac Cardiovasc Surg. 1982;84:505-514.
- Ellison N, Beatty
CP, Blake DR, Wurzel HA, MacVaugh H III. Heparin-rebound: studies
in patients and volunteers. J Thorac Cardiovasc Surg. 1974;67:723-729.
- Gollub S. Heparin
rebound in open heart surgery. Surg Gynecol Obstet. 1967;124:337-346.
- Pifarre R, Sullivan
HJ, Montoya A, Bakhos M, Grieco J, Foy BKB, Blakeman B. Management
of blood loss and heparin rebound following cardiopulmonary bypass.
Semin Thromb Hemost. 1989;15:173-177.
- Teoh KHT, Young
E, Bradley CA, Hirsh J. Heparin binding proteins: contribution to
heparin rebound after cardiopulmonary bypass. Circulation.
1993;88(pt 2):II-420- II-425.
- Jones TK, Barnes
RW, Greenfield LJ. Greenfield vena caval filter: rationale and current
indications. Ann Thorac Surg. 1986;42(suppl):S48-S55.
- Levine MN, Hirsh
J, Kelton JG. Heparin-induced bleeding. In: Lane DA, Lindahl U, eds.
Heparin: Chemical and Biological Properties, Clinical Applications.
London, UK: Edward Arnold; 1989:517-532.
- Green D, Lee
MY, Ito VY, Cohn T, Press J, Filbrandt PR, VandenBerg WC, Yarkony
GM, Meyer PR Jr. Fixed- vs adjusted-dose heparin in the prophylaxis
of thromboembolism in spinal cord injury. JAMA. 1988;260:1255-1258.
- Wilson JR, Lampman
J. Heparin therapy: a randomized prospective study. Am Heart J.
1979;97:155-158.
- Levine MN, Hirsh
J, Landefeld S, Raskob G. Hemorrhagic complications of anticoagulant
treatment. Chest. 1992;102(suppl):352S-363S.
- Yett HS, Skillman
JJ, Salzman EW. The hazards of aspirin plus heparin. N Engl J Med.
1978;298:1092. Letter.
- Sethi GK, Copeland
JG, Goldman S, Moritz T, Zadina K, Henderson WG. Implications of preoperative
administration of aspirin in patients undergoing coronary artery bypass
grafting: Department of Veterans Affairs Cooperative Study on Antiplatelet
Therapy. J Am Coll Cardiol. 1990;15:15-20.
- GISSI-2. A factorial
randomised trial alteplase versus streptokinase and heparin versus
no heparin among 12,490 patients with acute myocardial infarction:
Gruppo Italiano per lo Studio della Sopravvivenza Nell'infarto Miocardico.
Lancet. 1990;336:65-71.
- ISIS-3: a randomised
comparison of streptokinase vs tissue plasminogen activator vs anistreplase
and of aspirin plus heparin vs aspirin alone among 41,299 cases of
suspected acute myocardial infarction. Lancet. 1992;339:753-770.
- Urokinase-Pulmonary
Embolism Trial: morbidity and mortality. Circulation. 1973;58:II-66-II-72.
- Norman CS, Provan
JL. Control and complications of intermittent heparin therapy. Surg
Gynecol Obstet. 1977;145:338-342.
- King DJ, Kelton
JG. Heparin-associated thrombocytopenia. Ann Intern Med. 1984;100:535-540.
- Warkentin TE,
Kelton JG. Heparin-induced thrombocytopenia. Annu Rev Med.
1989;40:31-44.
- Ginsberg JS,
Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R, Coates G, Webber
C. Heparin effect on bone density. Thromb Haemost. 1990;64:286-289.
- Avioli LV. Heparin-induced
osteopenia: an appraisal. Adv Exp Med Biol. 1975;52:375-387.
- Dahlman T, Lindvall
N, Hellgren M. Osteopenia in pregnancy during long-term heparin treatment:
a radiological study post partum. Br J Obstet Gynaecol. 1990;97:221-228.
- Wise PH, Hall
AJ. Heparin-induced osteopenia in pregnancy. Br Med J. 1980;281:110-111.
- Squires JW,
Pinch LWC. Heparin-induced spinal fractures. JAMA. 1979;241:2417-2418.
- Griffiths HT,
Liu DTY. Severe heparin osteoporosis in pregnancy. Postgrad Med
J. 1984;60:424-425.
- White PW, Sadd
JR, Nensel RE. Thrombotic complications of heparin therapy: including
six cases of heparin-induced skin necrosis. Ann Surg. 1979;190:595-608.
- Abbott EC, Gornall
AG, Sutherland DJA, Laidlaw JC, Stiefel M. The influence of a heparin-like
compound on hypertension electrolytes and aldosterone in man. Can
Med Assoc J. 1966;94:1155-1164.
- Conn JW, Rovner
DR, Cohen EL, Anderson JE Jr. Inhibition by heparinoid of aldosterone
biosynthesis in man. J Clin Endocrinol Metab. 1966;26:527-532.
- Leehey D, Gantt
C, Lim V. Heparin-induced hypoaldosteronism: report of a case. JAMA.
1981;246:2189-2190.
- Phelps KR, Oh
MS, Carroll HJ. Heparin-induced hyperkalemia: report of a case. Nephron.
1980;25:254-258.
- Dukes GE Jr,
Sanders SW, Russo J Jr, Swenson E, Burnakis TG, Saffle JR, Warden
GD. Transaminase elevations in patients receiving bovine or porcine
heparin. Ann Intern Med. 1984;100:646-650.
- Nelson JC, Lerner
RG, Goldstein R, Cagin NA. Heparin-induced thrombocytopenia. Arch
Intern Med. 1978;138:548-552.
- Salzman EW,
Rosenberg RD, Smith MN, Lindon JN, Favreau L. Effect of heparin and
heparin fractions on platelet aggregation. J Clin Invest. 1980;65:64-73.
- Barradas MA,
Mikhailidis DP, Epemolu O, Jeremy JY, Fonseca V, Dandona P. Comparison
of the platelet pro-aggregatory effect of conventional unfractionated
heparins and a low molecular weight heparin fraction (CY 222). Br
J Haematol. 1987;67:451-457.
- Chong BH, Ismail
F. The mechanism of heparin-induced platelet aggregation. Eur J
Haematol. 1989;43:245-251.
- Chong BH, Pitney
WR, Castaldi PA. Heparin-induced thrombocytopenia: association of
thrombotic complications with heparin-dependent IgG antibody that
induces thromboxane synthesis and platelet aggregation. Lancet.
1982;2:1246-1249.
- Ansell J, Slepchuk
N Jr, Kumar R, Lopez A, Southard L, Deykin D. Heparin- induced thrombocytopenia:
a prospective study. Thromb Haemost. 1980;43:61-65.
- Ansell JE, Price
JM, Shah S, Beckner RR. Heparin-induced thrombocytopenia: what is
its real frequency? Chest. 1985;88:878-882.
- Bailey RT Jr,
Ursick JA, Heim KL, Hilleman DE, Reich JW. Heparin-associated thrombocytopenia:
a prospective comparison of bovine lung heparin, manufactured by a
new process, and porcine intestinal heparin. Drug Intell Clin Pharm.
1986;20:374-378.
- Ramirez-Lassepas
M, Cipolle RJ, Rodvold KA, Seifert RD, Strand L, Taddeini L, Cusulos
M. Heparin-induced thrombocytopenia in patients with cerebrovascular
ischemic disease. Neurology. 1984;34:736-740.
- Cipolle RJ,
Rodvold KA, Seifert R, Clarens R, Ramirez-Lassepas M. Heparin-associated
thrombocytopenia: a prospective evaluation of 211 patients. Ther
Drug Monit. 1983;5:205-211.
- Gallus AS, Goodall
KT, Beswick W, Chesterman CN. Heparin-associated thrombocytopenia:
case report and prospective study. Aust N Z J Med. 1980;10:25-31.
- Green D, Martin
GJ, Shoichet SH, DeBacker N, Bomalaski JS, Lind RN. Thrombocytopenia
in a prospective, randomized, double-blind trial of bovine and porcine
heparin. Am J Med Sci. 1984;288:60-64.
- Green D. Heparin-immune
thrombocytopenia. Med J Aust. 1986;144:37-39.
- Powers PJ, Cuthbert
D, Hirsh J. Thrombocytopenia found uncommonly during heparin therapy.
JAMA. 1979;241:2396-2397.
- Powers PJ, Kelton
JG, Carter CJ. Studies on the frequency of heparin-associated thrombocytopenia.
Thromb Res. 1984;33:439-443.
- Rao AK, White
GC, Sherman L, Colman R, Lan G, Ball AP. Low incidence of thrombocytopenia
with porcine mucosal heparin: a prospective multicenter study. Arch
Intern Med. 1989;149:1285-1288.
- Warkentin TE,
Kelton JG. Interaction of heparin with platelets, including heparin-induced
thrombocytopenia. In: Bounameaux H, ed. Low-Molecular-Weight Heparins
in Prophylaxis and Therapy of Thromboembolic Diseases. New York,
NY: Marcel Dekker Inc; 1994:75-127.
- Kapsch DN, Adelstein
EH, Rhodes GR, Silver D. Heparin-induced thrombocytopenia, thrombosis,
and hemorrhage. Surgery. 1979;86:148-155.
- Warkentin TE,
Kelton JG. Heparin-induced thrombocytopenia: predominance of venous
thrombotic complications, and a high risk for subsequent thrombosis
in patients who are initially recognized with isolated thrombocytopenia.
Blood. 1994;84(suppl 1):188A. Abstract.
- Kelton JG, Sheridan
D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG. Heparin-induced
thrombocytopenia: laboratory studies. Blood. 1988;72:925-930.
- Chong BH, Fawaz
I, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia: mechanism
of interaction of the heparin-dependent antibody with platelets. Br
J Haematol. 1989;73:235-240.
- Amiral J, Bridey
F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, Meyer D. Platelet factor
4 complexed to heparin is the target for antibodies generated in heparin-induced
thrombocytopenia. Thromb Haemost. 1992;68:95-96. Letter.
- Kelton JG, Smith
JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P. Immunoglobulin
G from patients with heparin-induced thrombocytopenia binds to a complex
of heparin and platelet factor 4. Blood. 1994;83:3232-3239.
- Visentin GP,
Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced
thrombocytopenia/thrombosis are specific for platelet factor 4 complexed
with heparin or bound to endothelial cells. J Clin Invest.
1994;93:81-88.
- Greinacher A,
Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated
thrombocytopenia: isolation of the antibody and characterization of
a multimolecular PF4-heparin complex as the major antigen. Thromb
Haemost. 1994;71:247-251.
- Chong BH, Murray
B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin
is increased in thrombotic consumptive platelet disorders. Blood.
1994;83:1535-1541.
- Warkentin TE,
Hayward CPM, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG.
Sera from patients with heparin-induced thrombocytopenia generate
platelet-derived microparticles with procoagulant activity: an explanation
for the thrombotic complications of heparin-induced thrombocytopenia.
Blood. 1994;84:3691-3699.
- Cines DB, Tomaski
A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated
thrombocytopenia. N Engl J Med. 1987;316:581-589.
- Sheridan D,
Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia.
Blood. 1986;67:27-30.
- Greinacher A,
Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test
for diagnosing heparin-associated thrombocytopenia. Thromb Haemost.
1991;66:734-736.
- Chong BH, Burgess
J, Ismail F. The clinical usefulness of the platelet aggregation test
for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost.
1993;69:344-350.
- Favaloro EJ,
Bernal-Hoyos E, Exner T, Koutts J. Heparin-induced thrombocytopenia:
laboratory investigation and confirmation of diagnosis. Pathology.
1992;24:177-183.
- Kelton JG, Sheridan
D, Brain H, Powers PJ, Turpie AGG, Carter CJ. Clinical usefulness
of testing for a heparin-dependent platelet-aggregating factor in
patients with suspected heparin-associated thrombocytopenia. J
Lab Clin Med. 1984;103:606-612.
- Greinacher A,
Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C. Laboratory
diagnosis of heparin-associated thrombocytopenia and comparison of
platelet aggregation test, heparin-induced platelet activation test,
and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion.
1994;34:381-385.
- Greinacher A,
Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia:
the antibody is not heparin specific. Thromb Haemost. 1992;67:545-549.
- Chong BH, Ismail
F, Cade J, Gallus AS, Gordon S, Chesterman CN. Heparin-induced thrombocytopenia:
studies with a new low molecular weight heparinoid, Org 10172. Blood.
1989;73:1592-1596.
- Magnani HN.
Heparin-induced thrombocytopenia (HIT): an overview of 230 patients
treated with orgaran (Org 10172). Thromb Haemost. 1993;70:554-561.
- Demers C, Ginsberg
JS, Brill-Edwards P, Panju A, Warkentin TE, Anderson DR, Turner C,
Kelton JG. Rapid anticoagulation using ancrod for heparin-induced
thrombocytopenia. Blood. 1991;78:2194-2197.
- Cole CW, Bormanis
J. Ancrod: a practical alternative to heparin. J Vasc Surg.
1988;8:59-63.
- Greinacher A,
Liebenhoff U, Kiefel V, Presek P, Mueller-Eckhardt C. Heparin-associated
thrombocytopenia: the effects of various intravenous IgG preparations
on antibody mediated platelet activation: a possible new indication
for high dose i.v. IgG. Thromb Haemost. 1994;71:641-645.
- Krishnamurti
C, Bolan CD, Reid TJ III, Alving BM. Pharmacology and mechanism of
action of ancrod: potential for inducing thrombosis. Blood.
1992;79:2492. Letter.
- Pitney WR, Holt
PJ, Bray C, Bolton G. Acquired resistance to treatment with arvin.
Lancet. 1969;1:79-81.
- Turpie AGG,
Gent M, Laupacis A, Latour Y, Wright D, Hoffman J, Gunstensen J, Basile
F, Klimek M, Hirsh J. Reduction in mortality by adding acetylsalicylic
acid (100 mg) to oral anticoagulants in patients with heart valve
replacement. Can J Cardiol. 1991;7(suppl A):95A. Abstract.
- Saour JN, Sieck
JO, Mamo LAR, Gallus AS. Trial of different intensities of anticoagulation
in patients with prosthetic heart valves. N Engl J Med. 1990;322:428-432.
- Landefeld CS,
Rosenblatt MW, Goldman L. Bleeding in outpatients treated with warfarin:
relation to the prothrombin time and important remediable lesions.
Am J Med. 1989;87:153-159.
- Landefeld CS,
Goldman L. Major bleeding in outpatients treated with warfarin: incidence
and prediction by factors known at the start of outpatient therapy.
Am J Med. 1989;87:144-152.
- Dale J, Myhre
E, Loew D. Bleeding during acetylsalicylic acid and anticoagulant
therapy in patients with reduced platelet reactivity after aortic
valve replacement. Am Heart J. 1980;99:746-752.
- Chesebro JH,
Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson
GK, Orszulak TA, Piehler JM, Schaff HV. Trial of combined warfarin
plus dipyridamole or aspirin therapy in prosthetic heart valve replacement:
danger of aspirin compared with dipyridamole. Am J Cardiol.
1983;51:1537-1541.
- Levine MN, Raskob
G, Hirsh J. Hemorrhagic complications of long-term anticoagulant therapy.
Chest. 1989;95(suppl):26S-36S.
- Altman R, Rouvier
J, Gurfinkel E, D'Ortencio O, Manzanel R, de La Fuente L, Favaloro
RG. Comparison of two levels of anticoagulant therapy in patients
with substitute heart valves. J Thorac Cardiovasc Surg. 1991;101:427-431.
- Petersen P,
Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled,
randomised trial of warfarin and aspirin for prevention of thromboembolic
complications in chronic atrial fibrillation: the Copenhagen AFASAK
Study. Lancet. 1989;1:175-179.
- Preliminary
report of the Stroke Prevention in Atrial Fibrillation Study. N
Engl J Med. 1990;322:863-868.
- Wells PS, Lensing
AWA, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the
diagnosis of deep venous thrombosis in asymptomatic patients after
orthopedic surgery: a meta-analysis. Ann Intern Med. 1995;122:47-53.
- Turpie AGG,
Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh
J. A comparison of aspirin with placebo in patients treated with warfarin
following heart-valve replacement. N Engl J Med. 1993;329:524-529.
- Turpie AGG,
Gunstensen J, Hirsh J, Nelson H, Gent M. Randomised comparison of
two intensities of oral anticoagulant therapy after tissue heart valve
replacement. Lancet. 1988;1:1242-1245.
- Stroke Prevention
in Atrial Fibrillation Study: final results. Circulation. 1991;84:527-539.
- The Boston Area
Anticoagulation Trial for Atrial Fibrillation Investigators. The effect
of low-dose warfarin on the risk of stroke in patients with nonrheumatic
atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
- Connolly SJ,
Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial
Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol.
1991;18:349-355.
- Ezekowitz MD,
Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf
H, Kurtzke JF, Nazarian SM, Radford MJ, et al. Warfarin in the prevention
of stroke associated with nonrheumatic atrial fibrillation: Veterans
Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
N Engl J Med. 1992;327:1406-1412.
- Broekmans AW,
Bertina RM, Loeliger EA, Hofmann V, Klingemann HG. Protein C and the
development of skin necrosis during anticoagulant therapy. Thromb
Haemost. 1983;49:251.
- Sherman DG,
Dyken ML, Fisher M, Harrison MJG, Hart RG. Antithrombotic therapy
for cerebrovascular disorders. Chest. 1989;95(suppl):140S-155S.
- Verhagen H.
Local hemorrhage and necrosis of the skin and underlying tissues at
starting therapy with dicumarol or dicumacyl. Acta Med Scand.
1954;148:453-467.
- Weinberg AC,
Lieskovsky G, McGehee WG, Skinner DG. Warfarin necrosis of the skin
and subcutaneous tissue of the male genitalia. J Urol. 1983;130:352-354.
- Zauber NP, Stark
MW. Successful warfarin anticoagulation despite protein C deficiency
and a history of warfarin necrosis. Ann Intern Med. 1986;104:659-660.
- Samama M, Horellou
MH, Soria J, Conard J, Nicolas G. Successful progressive anticoagulation
in a severe protein C deficiency and previous skin necrosis at the
initiation of oral anticoagulation treatment. Thromb Haemost.
1984;51:132-133. Letter.
- Grimaudo V,
Gueissaz F, Hauert J, Sarraj A, Kruithof EKO, Bachmann F. Necrosis
of skin induced by coumarin in a patient deficient in protein S. BMJ.
1989;298:233-234.
- Pabinger-Fasching
I, Deutsch E. Protein C deficiency in Austria. Semin Thromb Hemost.
1985;11:347-351.
- Hofmann V, Frick
PG. Repeated occurrence of skin necrosis twice following coumarin
intake and subsequently during decrease of vitamin K dependent coagulation
factors associated with cholestasis. Thromb Haemost. 1982;48:245-246.
- Sills RH, Marlar
RA, Montgomery RR, Deshpande GN, Humbert JR. Severe homozygous protein
C deficiency. J Pediatr. 1984;105:409-413.
- Estelles A,
Garcia-Plaza I, Dasi A, Aznar K, Duart M, Sanz G, Perez-Requejo JL,
Espana F, Jimenez C, Abeledo G. Severe inherited homozygous protein
C deficiency in a newborn infant. Thromb Haemost. 1984;52:53-56.
- Marciniak E,
Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder
related to the absence of protein C in blood. Blood. 1985;65:15-20.
- Branson HE,
Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive
chronic relapsing purpura fulminans in a newborn infant. Lancet.
1983;2:1165-1168.
- White RH, McKittrick
T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin
therapy: changes in the international normalized ratio. Ann Intern
Med. 1995;122:40-42.
- Risk factors
for stroke and efficacy of antithrombotic therapy in atrial fibrillation:
analysis of pooled data from five randomized controlled trials. Arch
Intern Med. 1994;154:1449-1457.
- Cannegieter
SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications
in patients with mechanical heart valve prostheses. Circulation.
1994;89:635-641.
- Shetty HG, Blackhouse
G, Bentley DP, Routledge PA. Effective reversal of warfarin-induced
excessive anticoagulation with low dose vitamin K1. Thromb
Haemost. 1992;67:13-15.
- Francis CW,
Marder VJ, Evarts CM, Yaukoolbodi S. Two step warfarin therapy: prevention
of postoperative venous thrombosis without excessive bleeding. JAMA.
1983;249:374-378.
- Hirsh J, Prins
MH, Samama M. Approach to the thrombophilic patient for hemostasis
and thrombosis: basic principles and clinical practice. In: Colman
W, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis:
Basic Principles and Clinical Practice. 3rd ed. Philadelphia,
Pa: JB Lippincott Co; 1994:1543-1561.
- Egeberg O. Inherited
antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh.
1965;13:516-530.
- Gladson CL,
Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous
protein S and protein C deficiency in 141 unrelated young patients
with venous thrombosis. Thromb Haemost. 1988;59:18-22.
- Heijboer H,
Brandjes DP, Buller HR, Sturk A, ten Cate, JW. Deficiencies of coagulation-inhibiting
and fibrinolytic proteins in outpatients with deep-vein thrombosis.
N Engl J Med. 1990;323:1512-1516.
- Coller BS, Owen
J, Jesty J, Horowitz D, Reitman MJ, Spear J, Yeh T, Comp PC. Deficiency
of plasma protein S, protein C, or antithrombin III and arterial thrombosis.
Arteriosclerosis. 1987;7:456-462.
- Allaart CF,
Aronson DC, Ruys T, Rosendaal FR, van Bockel JH, Bertina RM, Briet
E. Hereditary protein S deficiency in young adults with arterial occlusive
disease. Thromb Haemost. 1990;64:206-210.
- Bovill EG, Bauer
KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous
protein C deficiency in a large New England kindred. Blood.
1989;73:712-717.
- Mannucci PM,
Tripodi A, Bertina RM. Protein S deficiency associated with juvenile
arterial and venous thromboses. Thromb Haemost. 1986;55:440.
Letter.
- Broekmans AW,
Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous
thromboembolism: a study in three Dutch families. N Engl J Med.
1983;309:340-344.
- Horellou MH,
Conard J, Bertina RM, Samama M. Congenital protein C deficiency and
thrombotic disease in nine French families. Br Med J (Clin Res
Ed). 1984;289:1285-1287.
- Rodgers GM.
Activated protein C resistance and inherited thrombosis. Am J Clin
Pathol. 1995;103:261-262.
- Dahlback B,
Carlsson M, Svensson PJ. Familial thrombophilia due to a previously
unrecognized mechanism characterized by poor anticoagulant response
to activated protein C: prediction of a cofactor to activated protein
C. Proc Natl Acad Sci U S A. 1993;90:1004-1008.
- Koster T, Rosendaal
FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis
due to poor anticoagulant response to activated protein C: Leiden
Thrombophilia Study. Lancet. 1993;342:1503-1506.
- Svensson PJ,
Dahlback B. Resistance to activated protein C as a basis for venous
thrombosis. N Engl J Med. 1994;330:517-522.
- Griffin JHY,
Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway
defective in majority of thrombophilic patients. Blood. 1993;82:1989-1993.
- Bertina RM,
Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der
Velden PA, Reitsma RH. Mutation in blood coagulation factor V associated
with resistance to activated protein C. Nature. 1994;369:64-67.
- Vandenbroucke
JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased
risk of venous thrombosis in oral-contraceptive users who are carriers
of factor V Leiden mutation. Lancet. 1994;344:1453-1457.
- Triplett DA,
Brandt JT. Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon.
Hematol Pathol. 1988;2:121-143.
- Benifla JL,
Madelenat P. Hyperstimulation ofareienne et risque thrombogene. Arteres
et Veines. 1990;8:748.
- Clarke CS, Otridge
BW, Carney DN. Thromboembolism: a complication of weekly chemotherapy
in the treatment of non-Hodgkin's lymphoma. Cancer. 1990;66:2027-2030.
- Prins MH, Hirsh
J. A critical review of the evidence supporting a relationship between
impaired fibrinolytic activity and venous thromboembolism. Arch
Intern Med. 1991;151:1721-1731.
- Le DT, Griffin
JH, Greengard JS, Mujumdar V, Rapaport SI. Use of a generally applicable
tissue factor-dependent factor V assay to detect activated protein
C-resistant factor Va in patients receiving warfarin and in patients
with a lupus anticoagulant. Blood. 1995;85:1704-1711.
- Conley CL, Rathburn
HK, Monse WI II, Robinson JE Jr. Circulating anticoagulant as a cause
of hemorrhagic diathesis in man. Bull Johns Hopkins Hospital.
1948;83:288-296.
- Bowie EJW, Thompson
JH, Pascuzzi CA, Owen CA Jr. Thrombosis in systemic lupus erythematosus
despite circulating anticoagulants. J Lab Clin Med. 1963;62:416-430.
- Asherson RA,
Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJB, Barquinero J, Outt
HH, Harris EN, Vilardell-Torres M, Hughes GR. The primary antiphospholipid
syndrome: major clinical and serological features. Medicine (Baltimore).
1989;68:366-374.
- Alarcon-Segovia
D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes
J, Fernandez L, Ponce de Leon S. Antiphospholipid antibodies and the
antiphospholipid syndrome in systemic lupus erythematosus: a prospective
analysis of 500 consecutive patients. Medicine (Baltimore).
1989;68:353-365.
- Love PE, Santoro
SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant
in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence
and clinical significance. Ann Intern Med. 1990;112:682-698.
- Lockshin MD.
Antiphospholipid antibody syndrome. JAMA. 1992;268:1451-1453.
- Kitchens CS.
Prolonged activated partial thromboplastin time of unknown etiology:
a prospective study of 100 consecutive cases referred for consultation.
Am J Hematol. 1988;27:38-45.
- Derksen RHWM,
Hasselaar P, Blokzijl L, Gmelig Meyling FH, De Groot PG. Coagulation
screen is more specific than the anticardiolipin antibody ELISA in
defining a thrombotic subset of lupus patients. Ann Rheum Dis.
1988;47:364-371.
- Harris EN, Gharavi
AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR. Anticardiolipin
antibodies: detection by radioimmunoassay and association with thrombosis
in systemic lupus erythematosus. Lancet. 1983;2:1211-1214.
- Triplett DA,
Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants
and antibodies to phosphilipid. JAMA. 1988;259:550-554.
- Levine SR, Kieran
S, Puzio K, Feit H, Patel SC, Welch KM. Cerebral venous thrombosis
with lupus anticoagulants: report of two cases. Stroke. 1987;18:801-804.
- Moreb J, Kitchens
CS. Acquired functional protein S deficiency, cerebral venous thrombosis,
and coumarin skin necrosis in association with antiphospholipid syndrome:
report of two cases. Am J Med. 1989;87:207-210.
- Pertuiset E,
Tribout B, Wechsler B, Bellin MF, Godeau P, Jian R, Rambaud JC. Systemic
lupus erythematosus presenting with portal venous thrombosis. Am
J Med. 1989;86:501-502.
- Case records
of the Massachusetts General Hospital--weekly clinicopathological
exercises: case 11-1990, a 38-year-old woman with fever, skin lesions,
thrombocytopenia, and venous thromboses. N Engl J Med. 1990;322:754-769.
- Glueck HI, Kant
KS, Weiss MA, Pollak VE, Miller MA, Coots M. Thrombosis in systemic
lupus erythematosus: relation to the presence of circulating anticoagulants.
Arch Intern Med. 1985;145:1389-1395.
- Mintz G, Acevedo-Vazquez
E, Gutierrez-Espinosa G, Avelar-Garnica F. Renal vein thrombosis and
inferior vena cava thrombosis in systemic lupus erythematosus: frequency
and risk factors. Arthritis Rheum. 1984;27:539-544.
- Yap AS, Powell
EE, Yelland CE, Mortimer RH, Perry-Keene DA. Lupus anticoagulant.
Ann Intern Med. 1989;111:262-263.
- Lechner K, Pabinger-Fasching
I. Lupus anticoagulants and thrombosis: a study of 25 cases and review
of the literature. Haemostasis. 1985;15:254-262.
- Gastineau DA,
Kazmier FJ, Nichols WL, Bowie EJ. Lupus anticoagulant: an analysis
of the clinical and laboratory features of 219 cases. Am J Hematol.
1985;19:265-275.
- Gardlund B.
The lupus inhibitor in thromboembolic disease and intrauterine death
in the absence of systemic lupus. Acta Med Scand. 1984;215:293-298.
- Asherson RA,
Merry P, Acheson JF, Harris EN, Hughes GR. Antiphospholipid antibodies:
a risk factor for occlusive ocular vascular disease in systemic lupus
erythematosus and the "primary antiphospholipid syndrome."
Ann Rheum Dis. 1989;48:358-361.
- Heckerling PS,
Froelich CJ, Schade SG. Retinal vein thrombosis in a patient with
pernicious anemia and anticardiolipin antibodies. J Rheumatol.
1989;16:1144-1146.
- Rao RH, Vagnucci
AH, Amico JA. Bilateral massive adrenal hemorrhage: early recognition
and treatment. Ann Intern Med. 1989;110:227-235.
- Carette S, Jobin
F. Acute adrenal insufficiency as a manifestation of the anticardiolipin
syndrome? Ann Rheum Dis. 1989;48:430-431.
- Alperin N, Babu
S, Weinstein A. Acute adrenal insufficiency and the antiphospholipid
syndrome. Ann Intern Med. 1989;111:950. Letter.
- Pope JM, Canny
CLB, Bell DA. Cerebral ischemic events associated with endocarditis,
retinal vascular disease, and lupus anticoagulant. Am J Med.
1991;90:299-309.
- Ostermiller
W Jr, Carter R. Mesenteric venous thrombosis secondary to polycythemia
vera. Am Surg. 1969;35:407-409.
- Kneeland JB,
Auh YH, Zirinsky K, Rubenstein W, Kazam E. MR, CT, and ultrasonographic
demonstration of splenic vein thrombosis. J Comput Assist Tomogr.
1984;8:1199-1200.
- Shaldon S, Sherlock
L. Portal hypertension in the myeoloproliferative syndrome and the
reticuloses. Am J Med. 1962;32:758-764.
- Conlan MG, Haire
WD. Low protein S in essential thrombocythemia with thrombosis. Am
J Hematol. 1989;32:88-93.
- Teofili L, De
Stefano V, Leone G, Micalizzi P, Iovino MS, Alfano G, Bizzi B. Hematological
causes of venous thrombosis in young people: high incidence of myeloproliferative
disorder as underlying disease in patients with splanchnic venous
thrombosis. Thromb Haemost. 1992;67:297-301.
- White CL, Brewer
ML, Witte MH, Pond GB. Protean manifestations of pylethrombosis: a
review of thirty-four patients. Ann Surg. 1985;202:191-202.
- Wasserman LR,
Gilbert HS. Complications of polycythemia vera. Semin Hematol.
1966;3:199-208.
- Jabaily J, Iland
HJ, Laszlo J, Massey EW, Faguet GB, Briere J, Landaw SA, Pisciotta
AV. Neurologic manifestations of essential thrombocythemia. Ann
Intern Med. 1983;99:513-518.
- Singh AK, Wetherley-Mein
G. Microvascular occlusive lesions in primary thrombocythaemia. Br
J Haematol. 1977;36:553-564.
- Conley CL. Polycythemia
vera. JAMA. 1990;263:2481-2483.
- Anagrelide Study
Group. Anagrelide, a therapy for thrombocythemic states: experience
in 577 patients. Am J Med. 1992;92:69-76.
- Cortelazzo S,
Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T. Incidence
and risk factors for thrombotic complications in a historical cohort
of 100 patients with essential thrombocythemia. J Clin Oncol.
1990;8:556-562.
- Cortelazzo S,
Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, Barbui T. Hydroxyurea
for patients with essential thrombocythemia and a high risk of thrombosis.
N Engl J Med. 1995;332:1132-1136.
- McIntyre KJ,
Hoagland HC, Silverstein MN, Petitt RM. Essential thrombocythemia
in young adults. Mayo Clin Proc. 1991;66:149-154.
- Liu PG, Jacobs
JB, Reede D. Trousseau's syndrome in the head and neck. Am J Otolaryngol.
1985;6:405-408.
- James WD. Trousseau's
syndrome. Int J Dermatol. 1984;23:205-206.
- Hickey WF, Garnick
MB, Henderson IC, Dawson DM. Primary cerebral venous thrombosis in
patients with cancer. A rarely diagnosed paraneoplastic syndrome:
report of three cases and a review of the literature. Am J Med.
1982;73:740-750.
- Sack GH Jr,
Levin J, Bell WR. Trousseau's syndrome and other manifestations of
chronic disseminated coagulopathy in patients with neoplasms: clinical,
pathophysiologic and therapeutic features. Medicine (Baltimore).
1977;56:1-37
|